Most recent articles by:

Jean Connors

Jean Connors, M.D., is a hematology attending physician at Brigham and Women’s Hospital and Dana Farber Cancer Institute; the Medical Director of the Anticoagulation Management Services, and the Hemostatic Antithrombotic Stewardship Program; and an Associate Professor of Medicine at Harvard Medical School. She is also a Scientific Steering Committee member for the World Thrombosis Day Campaign. She received a medical degree from The Johns Hopkins University in Baltimore, MD, completed her residency in internal medicine at Beth Israel Deaconess Medical Center in Boston, MA, as well as fellowships in transfusion medicine and hematology and oncology from Brigham and Women’s Hospital. Dr. Connors is an Associate Editor for the Journal of Thrombosis and Haemostasis (JTH) and she is a member of many professional societies, including the American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH). She has participated in numerous clinical trials for patients with venous thrombosis in cancer and anticoagulation questions in general.
- Advertisement -

The Evolution of Treatment: Use of Anticoagulation in Cancer Patients

Cancer patients face many heightened health risks after their initial diagnosis. While the disease itself is a leading cause of death worldwide,...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC
- Advertisement -